SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
March 28, 2000
(Date of earliest event reported)
PHYMED, INC.
(Exact name of registrant as specified in its charter)
OKLAHOMA 73-1457920
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
0-10701
(Commission File Number)
9603 White Rock Trail, Suite 100
Dallas, Texas 75238
(Address of principal executive offices)
(214) 340-9912
(Registrant's telephone number, including area code)
<PAGE>
Item 4. Changes in Registrant's Certifying Accountant
The last audit of the Registrant's financial statements was for its
fiscal year ended December 31, 1998. Grant Thornton LLP performed the audit.
On March 28, 2000, the Registrant and Grant Thornton LLP terminated
their previous audit relationship.
During the last two years, no audit report of Grant Thornton LLP on the
financial statements of the Registrant contained any adverse opinion or a
disclaimer of opinion, or was modified as to audit scope or accounting
principles, except that Grant Thornton LLP modified both 1997 &1998 audit
reports as to uncertainty related to the Registrant's ability to continue as a
going concern.
There were no disagreements with Grant Thornton LLP on any matter of
accounting principles or practices, financial statement disclosure, or auditing
scope or procedure during the Registrant's two most recent fiscal years and any
subsequent interim period preceding such termination.
The decision to dismiss accountants was approved by the Registrant's
Board of Directors.
Item 7. Financial Statements and Exhibits
(a) Financial statements of business acquired.
Not applicable
(b) Proforma financial information
Not applicable
(c) Exhibits
16. Letter dated March 31, 2000, from Grant Thornton LLP.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereto duly authorized.
Date: March 4, 2000 PHYMED, INC.
(Registrant)
/s/ George C. Barker
-------------------------------------
George C. Barker
President and Chief Executive Officer
/s/ David L. Moore
-------------------------------------
Chief Financial Officer
March 27, 2000
Securities and Exchange Commission
450 Fifth Street, NW
Washington, D.C. 20549
Gentlemen:
We have read and agree with the comments in Item 4 of Form 8-K of PhyMed, Inc.
(commission file no. 0-10701) dated March 28, 2000 and are in agreement with the
statements contained therein. We are not in a position to agree or disagree with
the fifth paragraph.
/s/ Grant Thornton LLP
- ---------------------------
Grant Thornton LLP
